ETFs Illumina, Inc.

ILMN

US4523271090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2024-09-17 EDT			5-day change	1st Jan Change
130.21 ^USD	+0.53%		+4.90%	-6.49%

09-13	RBC Raises Price Target on Illumina to $252 From $242, Keeps Outperform Rating	MT
09-06	European Commission Withdraws Previous Decisions on Illumina-Grail Merger After Court Ruling	MT

ETFs positioned on Illumina, Inc.

Name	Weight	AuM	1st Jan change	Investor Rating
BMO MSCI GENOMIC INNOVATION INDEX ETF - CAD	4.11%	2 M€	-.--%
FIRST TRUST NYSE ARCA BIOTECHNOLOGY ETF - CAD	3.62%	1 M€	-.--%	-
LEVERAGE SHARES -3X SHORT BIOTECHNOLOGY ETP SECURITIES - USD	3.11%	0 M€	0.00%	-
LEVERAGE SHARES 3X LONG BIOTECHNOLOGY ETP SECURITIES - USD	3.03%	0 M€	0.00%	-
KELLY STRATEGIC CRISPR & GENE EDITING TECHNOLOGY ETF - USD	1.77%	2 M€	-25.75%
IQ U.S. MID CAP R&D LEADERS ETF - USD	1.60%	4 M€	+20.15%
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	1.59%	18 M€	+10.12%	-
BMO MSCI INNOVATION INDEX ETF - CAD	1.53%	7 M€	-.--%	-
GLOBAL X ROBO GLOBAL ROBOTICS & AUTOMATION ETF - AUD	1.50%	143 M€	-4.82%
DIREXION NASDAQ-100 EQUAL WEIGHTED ETF - USD	1.02%	1,235 M€	+4.57%
HAN-GINS INDXX HEALTHCARE MEGATREND EQUAL WEIGHT UCITS ETF - ACC - USD	0.99%	15 M€	+0.31%
NATIXIS U.S. EQUITY OPPORTUNITIES ETF - USD	0.80%	9 M€	+15.45%	-
CSIF (IE) MSCI USA TECH 125 ESG UNIVERSAL BLUE UCITS ETF B - USD	0.63%	44 M€	-.--%
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD	0.43%	7 M€	0.00%
AMUNDI INDEX MSCI USA SRI PAB UCITS ETF - EUR	0.43%	4,592 M€	-.--%
ARMOR US EQUITY INDEX ETF - USD	0.36%	9 M€	-.--%	-
LEVERAGE SHARES 5X LONG US TECH 100 ETP SECURITIES - USD	0.30%	27 M€	0.00%	-
UBS (IRL) ETF PLC S&P 500 ESG ELITE UCITS ETF A-ACC - HEDGED CHF	0.30%	1 M€	+16.32%
ADVOCATE RISING RATE HEDGE ETF - USD	0.30%	5 M€	-72.95%	-
LEVERAGE SHARES -3X SHORT US TECH 100 ETP SECURITIES - USD	0.29%	3 M€	0.00%	-
LEVERAGE SHARES 3X LONG US TECH 100 ETP SECURITIES - USD	0.29%	1 M€	0.00%	-
UBS (IRL) ETF PLC MSCI USA SOCIALLY RESPONSIBLE UCITS ETF A-DIS - HEDGED EUR	0.26%	2 M€	+20.44%	-
CSIF (IE) MSCI USA ESG LEADERS BLUE UCITS ETF - B - USD	0.26%	2,805 M€	+17.41%
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	0.23%	2 M€	+13.77%
AMUNDI INDEX MSCI WORLD SRI PAB UCITS ETF - EUR	0.23%	3,859 M€	+18.82%
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR - HEDGED EUR (C)	0.23%	469 M€	-1.75%
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - EUR	0.18%	270 M€	-.--%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - CHF	0.17%	209 M€	+14.54%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - B - USD	0.17%	458 M€	-.--%
AMUNDI MSCI USA ESG LEADERS SELECT - UCITS ETF DR (C) - USD	0.17%	1,448 M€	-.--%	-

1 2 3 4

Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (15.9%). Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).

Employees

10,615

Sector

Advanced Medical Equipment & Technology

Calendar

2024-10-30 - Q3 2024 Earnings Release (Projected)

More about the company